COVID-19 Featured Question
My local IRB can’t meet due to COVID-19 restrictions, and so my clinical trial might be suspended. Can Advarra help?
Read the answer | Ask the experts
Press Release
IRB Services
IBC Services
GxP/HRP Consulting Services
Canadian Review
Trust Advarra’s integrated solutions and collaborative approach to make your research altogether better.
Advarra® provides institutional review board (IRB), institutional biosafety committee (IBC) and GxP/HRP research compliance consulting services with unprecedented clarity.
Advarra recently acquired Forte, the market-leading provider of clinical technology solutions including OnCore. Learn more
Our Latest Updates
Discover What’s Happening at Advarra
Health Canada Notification on Clinical Trial Management During COVID-19 Pandemic
In response to the current COVID-19 public health emergency, Health Canada has published the notification Management of clinical trials during...
Evaluating Payment to Participate in Research: Ethical and Regulatory Issues
Luke Gelinas, IRB Chairperson at Advarra, proposes a practical framework for evaluating offers of payment and applies it to case studies to yield guidance on challenging ethical and regulatory issues…
IRB Review of Coronavirus and Other Emerging Infectious Disease Research: Issues to Consider
In this blog we discuss unique issues that research involving emerging infectious diseases like coronavirus can raise for IRB review and research informed consent.
Are “Virtual Trials” Mainstream Yet?
While some completely virtual trials are taking place, the real trend involves bringing virtual trial components to traditional study designs to improve study efficiency and reduce participant burden.